December 2, 2022
“Overprescribing among older people near end of life in Ireland: Evidence of prevalence and determinants from The Irish Longitudinal Study on Ageing (TILDA),” by Soraya Matthews, Frank Moriarty, Mark Ward, Anne Nolan, Charles Normand, Rose Anne Kenny, and Peter May (PLoS ONE 17(9): e0273948. doi.org/10.1371/journal.pone.0273948, XML, HTML, and .pdf format, 15p.).
journals.plos.org/plosone/article?id=10.1371/journal.pone.0273948
Comments Off on CAAR – Public Library of Science (PLoS) Article – December 2, 2022
October 28, 2022
“Drug use among seniors in Canada,” (October 2022, HTML and Excel format).
www.cihi.ca/en/drug-use-among-seniors-in-canada
Comments Off on CAAR – Canadian Institute for Health Information/Institut Canadien D’information Sur La Sante Report – October 28, 2022
October 19, 2022
“Prescription Drug Spending in Fee-for-Service Medicare, 2008-2019,” by Stacie B. Dusetzina, Haiden A. Huskamp, Xuanzi Qin, and Nancy L. Keating (Vol. 328, No. 15, October 18, 2022, p. 1515-1522).
jamanetwork.com/journals/jama/article-abstract/2797420
Comments Off on CAAR – Journal of the American Medical Association Article Abstract – October 19, 2022
September 29, 2022
“Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2020 Average Sales Prices,” (OEI-03-22-00170, September 2022, .pdf format, 7p.).
oig.hhs.gov/oei/reports/OEI-03-22-00170.asp
Comments Off on CAAR – US Department of Health and Human Services, Office of Inspector General Report – September 29, 2022
August 25, 2022
“How Will the Prescription Drug Provisions in the Inflation Reduction Act Affect Medicare Beneficiaries?” by Juliette Cubanski, Tricia Neuman, Meredith Freed, and Anthony Damico (August 2022, HTML and .pdf format, 8p.).
www.kff.org/medicare/issue-brief/how-will-the-prescription-drug-provisions-in-the-inflation-reduction-act-affect-medicare-beneficiaries/
Comments Off on CAAR – Kaiser Family Foundation Issue Brief – August 25, 2022
August 24, 2022
“Lowering Health Care Costs for Nevada Seniors: Taking Action to Bring Down Prescription Drug Prices,” a hearing held August 23, 2022 (witness statements available in .pdf format, video of the full hearing available at the site, running time 1 hour 35 minutes). Note: Hearing begins at the 15:05 mark.
www.aging.senate.gov/hearings/lowering-health-care-costs-for-nevada-seniors-taking-action-to-bring-down-prescription-drug-prices
Comments Off on CAAR – US Senate Special Committee on Aging Hearing Testimony – August 24, 2022
August 17, 2022
“Utilization Management for Prescription Drugs Commonly Used by Older Adults: Wide State Variation Among Top Marketplace Plans,” by James McSpadden (August 2022, .pdf format, 5p.).
www.aarp.org/ppi/info-2022/utilization-management-for-prescription-drugs.html
Comments Off on CAAR – AARP Public Policy Institute Report – August 17, 2022
August 11, 2022
“Part D Plan Preference for Higher-Cost Hepatitis C Drugs Led to Higher Medicare and Beneficiary Spending,” (OEI-BL-21-00200, August 2022, .pdf format, 35p.).
oig.hhs.gov/oei/reports/OEI-BL-21-00200.asp
Comments Off on CAAR – US Department of Health and Human Services, Office of Inspector General Report – August 11, 2022
July 28, 2022
“How Would the Prescription Drug Provisions in the Senate Reconciliation Proposal Affect Medicare Beneficiaries?” by Juliette Cubanski, Tricia Neuman, Meredith Freed, and Anthony Damico (July 2022, .pdf and HTML format, 8p.).
www.kff.org/medicare/issue-brief/how-would-the-prescription-drug-provisions-in-the-senate-reconciliation-proposal-affect-medicare-beneficiaries/
Comments Off on CAAR – Kaiser Family Foundation Issue Brief – July 28, 2022
July 12, 2022
“Affordable Prescriptions Now: Examining Legislation to Lower Costs for Seniors,” a hearing held July 1, 2022 (witness statements available in .pdf format, video of the full hearing available at the site, running time 2 hours 18 minutes). Note: Hearing begins aa the 31:33 mark.
www.aging.senate.gov/hearings/affordable-prescriptions-now-examining-legislation-to-lower-costs-for-seniors
Comments Off on CAAR – US Senate Special Committee on Aging Hearing Testimony – July 12, 2022
May 5, 2022
“Potentially Inappropriate Medication Prescribed to Seniors,” (May 2022, Excel format).
www.cihi.ca/en/indicators/potentially-inappropriate-medication-prescribed-to-seniors
Comments Off on CAAR – Canadian Institute for Health Information/Institut Canadien D’information Sur La Sante Data Tables – May 5, 2022
April 18, 2022
“Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients,” by Kin Wah Fung, Seo H. Baik, Fitsum Baye, Zhaonian Zheng, Vojtech Huser, and Clement J. McDonald (PLoS ONE 17(4): e0266922. doi.org/10.1371/journal.pone.0266922, XML, HTML, and .pdf format, 15p.).
journals.plos.org/plosone/article?id=10.1371/journal.pone.0266922
Comments Off on CAAR – Public Library of Science (PLoS) Article – April 18, 2022
April 12, 2022
“No Time to Wait: Proposals to Lower Prescription Drug Costs,” a hearing held April 12, 2022 (witness statements available in .pdf format, video of the full hearing available at the site, running time 1 hour 6 minutes). Note: Hearing begins at the 13:00 mark.
www.aging.senate.gov/hearings/no-time-to-wait-proposals-to-lower-prescription-drug-costs
Comments Off on CAAR – US Senate Special Committee on Aging Hearing Testimony – April 12, 2022
April 8, 2022
A. “Over 9 Million Adults Ages 50 and Older Faced Food Insecurity in 2020,” by Olivia Dean and Carlos Figueiredo (March 2022, .pdf format, 6p.).
www.aarp.org/ppi/info-2022/food-insecurity-adults-50-and-older.html
B. “Trends in Utilization Management of Prescription Drugs in Top Marketplace Plans,” by James McSpadden (April 2022, .pdf format, 6p.).
www.aarp.org/ppi/info-2022/trends-utilization-management-top-drug-plans.html%20/
Comments Off on CAAR – AARP Public Policy Institute Reports – April 8, 2022
April 7, 2022
“2023 Medicare Advantage rate book and Prescription Drug rate information,” (March 2022, zipped comma-delimited and Excel format).
www.cms.gov/medicarehealth-plansmedicareadvtgspecratestatsratebooks-and-supporting-data/2023
Comments Off on CAAR – US Centers for Medicare and Medicaid Services Data Release – April 7, 2022
April 1, 2022
“Medicare Part D and Beneficiaries Could Realize Significant Spending Reductions With Increased Biosimilar Use,” (OEI-05-20-00480, March 2022, .pdf format, 33p.).
oig.hhs.gov/oei/reports/OEI-05-20-00480.asp
Comments Off on CAAR – US Department of Health and Human Services, Office of Inspector General Report – April 1, 2022
March 16, 2022
“Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare,” a hearing held March 16, 2022 (witness statements available in .pdf format, video of the full hearing available at the site, running time 2 hours 44 minutes). Note: The hearing begins at the 20:49 mark.
www.finance.senate.gov/hearings/prescription-drug-price-inflation-an-urgent-need-to-lower-drug-prices-in-medicare
Comments Off on CAAR – US Senate Committee on Finance Hearing Testimony – March 16, 2022
February 25, 2022
“Prices Increased Faster Than Inflation for Half of all Drugs Covered by Medicare in 2020,” by Juliette Cubanski and Tricia Neuman (February 2022, .pdf and HTML format, 8p.).
www.kff.org/medicare/issue-brief/prices-increased-faster-than-inflation-for-half-of-all-drugs-covered-by-medicare-in-2020/
Comments Off on CAAR – Kaiser Family Foundation Issue Brief – February 25, 2022
February 8, 2022
A. “The Prices That Commercial Health Insurers and Medicare Pay for Hospitals’ and Physicians’ Services,” (January 2022, .pdf and HTML format, 45p.).
www.cbo.gov/publication/57422
B. “Prescription Drugs: Spending, Use, and Prices,” (January 2022, .pdf and HTML format, 23p.).
www.cbo.gov/publication/57050
Comments Off on CAAR – US Congressional Budget Office Reports – February 8, 2022
January 28, 2022
“Simulating the Impact of the Drug Price Negotiation Proposal in the Build Back Better Act,” by Juliette Cubanski, Nolan Sroczynski, and Tricia Neuman (January 2022, .pdf and HTML format, 8p.).
www.kff.org/medicare/issue-brief/simulating-the-impact-of-the-drug-price-negotiation-proposal-in-the-build-back-better-act/
Comments Off on CAAR – Kaiser Family Foundation Issue Brief – January 28, 2022
January 14, 2022
“Medication Literacy: A Helpful Concept for Understanding Medication Decision Making among Older Adults,” by James McSpadden (January 2022, .pdf format, 7p.).
www.aarp.org/ppi/info-2022/medication-literacy.html
Comments Off on CAAR – AARP Public Policy Institute Report – January 14, 2022
November 30, 2021
“CMS Should Strengthen Its Prescription Drug Event Guidance To Clarify Reporting of Sponsor Margin for Medicare Part D Bids,” (A-03-17-00001, November 2021, .pdf format, 15p.).
oig.hhs.gov/oas/reports/region3/31700001.asp
Comments Off on CAAR – US Department of Health and Human Services, Office of Inspector General Report – November 30, 2021
November 29, 2021
“Explaining the Prescription Drug Provisions in the Build Back Better Act,” by Juliette Cubanski, Tricia Neuman, and Meredith Freed (November 2021, .pdf and HTML format, 14p.).
www.kff.org/medicare/issue-brief/explaining-the-prescription-drug-provisions-in-the-build-back-better-act/
Comments Off on CAAR – Kaiser Family Foundation Report – November 29, 2021
November 23, 2021
“Brand-Name Drug Prices: The Key Driver of High Pharmaceutical Spending in the U.S.: An International Comparison of Prescription Drug Spending and Costs,” by Aimee Cicchiello and Lovisa Gustafsson (November 2021, HTML, .pdf, and Powerpoint format, 11p.).
www.commonwealthfund.org/publications/2021/nov/brand-name-drug-prices-key-driver-high-pharmaceutical-spending-in-us
Comments Off on CAAR – Commonwealth Fund Brief – November 23, 2021
September 30, 2021
“Trends in Retail Prices of Specialty Prescription Drugs Widely Used by Older Americans, 2006 to 2020,” by Leigh Purvis and Dr. Stephen Schondelmeyer (September 2021, .pdf format, 30p.).
www.aarp.org/ppi/info-2019/trends-in-retail-prices-of-drugs.html
Comments Off on CAAR – AARP Public Policy Institute Report – September 30, 2021
August 12, 2021
“How Would Drug Price Negotiation Affect Medicare Part D Premiums?” by Juliette Cubanski and Tricia Neuman (August 2021, .pdf and HTML format, 3p.).
www.kff.org/medicare/issue-brief/how-would-drug-price-negotiation-affect-medicare-part-d-premiums/
Comments Off on CAAR – Kaiser Family Foundation Issue Brief – August 12, 2021
August 4, 2021
“Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016,” by Eric H. Young, Samantha Pan, Alex G. Yap, Kelly R. Reveles, and Kajal Bhakta (PLoS ONE 16(8): e0255642. doi.org/10.1371/journal.pone.0255642, XML, HTML, and .pdf format, 10p.).
journals.plos.org/plosone/article?id=10.1371/journal.pone.0255642
Comments Off on CAAR – Public Library of Science (PLoS) Article – August 4, 2021
June 28, 2021
“Novel Anticoagulants Achieve Rapid Market Penetration despite Higher Costs,” by Catherine W. Gillespie and Leigh Purvis (June 2021, .pdf format, 7p.).
www.aarp.org/ppi/info-2021/novel-anticoagulants-achieve-rapid-market-penetration-despite-higher-costs.html
Comments Off on CAAR – AARP Public Policy Institute Report – June 28, 2021
June 9, 2021
A. “Drug Price Increases That Exceed Inflation Are Costing Medicare Part D Billions,” by Leigh Purvis (June 2021, .pdf format, 5p.).
www.aarp.org/ppi/info-2021/drug-price-increases-that-exceed-inflation-are-costing-medicare.html
B. “Rx Price Watch Report: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans, 2006 to 2020,” by Leigh Purvis and Dr. Stephen Schondelmeyer (June 2021, .pdf format, p.).
www.aarp.org/ppi/info-2019/trends-in-retail-prices-of-drugs.html
Comments Off on CAAR – AARP Public Policy Institute Brief, Report – June 9, 2021
May 5, 2021
“Negotiating a Better Deal: Legislation to Lower the Cost of Prescription Drugs,” a hearing held May 4, 2021 (witness statements available in .pdf format, video of the full hearing available at the site, running time 4 hours 11 minutes). Note: The hearing begins at the 10:58 mark.
energycommerce.house.gov/committee-activity/hearings/hearing-on-negotiating-a-better-deal-legislation-to-lower-the-cost-of
Comments Off on CAAR – US House Committee on Energy and Commerce Hearing Testimony – May 5, 2021
April 28, 2021
“Prescription Drugs: U.S. Prices for Selected Brand Drugs Were Higher on Average than Prices in Australia, Canada, and France,” (GAO-21-282, March 2021, .pdf format, 65p.).
www.gao.gov/products/gao-21-282
Comments Off on CAAR – US Government Accountability Office Report – April 28, 2021
April 21, 2021
“Relatively Few Drugs Account for a Large Share of Medicare Prescription Drug Spending,” by Juliette Cubanski and Tricia Neuman (April 2021, HTML format).
www.kff.org/medicare/issue-brief/relatively-few-drugs-account-for-a-large-share-of-medicare-prescription-drug-spending/
Comments Off on CAAR – Kaiser Family Foundation Issue Brief – April 21, 2021
February 19, 2021
“A Comparison of Brand-Name Drug Prices Among Selected Federal Programs,” (February 2021, HTML and .pdf format, 34p.).
www.cbo.gov/publication/56978
Comments Off on CAAR – US Congressional Budget Office Report – February 19, 2021
February 8, 2021
“CBO’s Model of Drug Price Negotiations Under the Elijah E. Cummings Lower Drug Costs Now Act,” by Christopher Adams and Evan Herrnstadt (Working Paper 2021-01, February 2021, .pdf format, 28p.). Note: A link to the abstract and the full-text of this paper is available at:
www.cbo.gov/publication/56905
Comments Off on CAAR – US Congressional Budget Office Working Paper – February 8, 2021
February 5, 2021
“Price Increases Continue to Outpace Inflation for Many Medicare Part D Drugs,” by Juliette Cubanski and Tricia Neuman (February 2021, HTML format).
www.kff.org/medicare/issue-brief/price-increases-continue-to-outpace-inflation-for-many-medicare-part-d-drugs/
Comments Off on CAAR – Kaiser Family Foundation Brief – February 5, 2021
January 28, 2021
A. “Association of low back pain with muscle weakness, decreased mobility function, and malnutrition in older women: A cross-sectional study,” by Satoshi Kato, Satoru Demura, Kazuya Shinmura, Noriaki Yokogawa, Tamon Kabata, Hidenori Matsubara, Yoshitomo Kajino, Kentaro Igarashi, Daisuke Inoue, Yuki Kurokawa, Norihiro Oku, and Hiroyuki Tsuchiya (PLoS ONE 16(1): e0245879. doi.org/10.1371/journal.pone.0245879, HTML, XML, and .pdf format, 11p.).
journals.plos.org/plosone/article?id=10.1371/journal.pone.0245879
B. “Adipocyte-induced transdifferentiation of osteoblasts and its potential role in age-related bone loss,” by Aline Clabaut, Céline Grare, Gaëlle Rolland-Valognes, Jean-Guillaume Letarouilly, Chantal Bourrier, Thomas L. Andersen, Tanja Sikjær, Lars Rejnmark, Charlotte Ejersted, Philippe Pastoureau, Pierre Hardouin, Massimo Sabatini, and Odile Broux (PLoS ONE 16(1): e0245014. doi.org/10.1371/journal.pone.0245014, HTML, XML, and .pdf format, 17p.).
journals.plos.org/plosone/article?id=10.1371/journal.pone.0245014
C. “Identification of drug combinations on the basis of machine learning to maximize anti-aging effects,” by Sun Kyung Kim, Peter C. Goughnour, Eui Jin Lee, Myeong Hyun Kim, Hee Jin Chae, Gwang Yeul Yun, Yi Rang Kim, and Jin Woo Choi (PLoS ONE 16(1): e0246106. doi.org/10.1371/journal.pone.0246106, XML, HTML, and .pdf format, 19p.).
journals.plos.org/plosone/article?id=10.1371/journal.pone.0246106
Comments Off on CAAR – Public Library of Science (PLoS) Article – January 28, 2021
January 14, 2021
“Prescription Drugs: Department of Veterans Affairs Paid About Half as Much as Medicare Part D for Selected Drugs in 2017,” (GAO-21-111, December 2020, .pdf format, 23p.).
www.gao.gov/products/GAO-21-111
Comments Off on CAAR – US Government Accountability Office Report – January 14, 2021
December 29, 2020
“Out-of-Pocket Spending for Retail Prescribed Drugs by Age and Type of Prescription Drug Coverage, 2009 to 2018,” by William A. Carroll, G. Edward Carroll, and Steven C. Hill (Medical Expenditure Panel Survey Statistical Brief No. 532, December 2020, .pdf and HTML format, 11p.).
meps.ahrq.gov/mepsweb/data_stats/Pub_ProdResults_Details.jsp?pt=Statistical+Brief&opt=2&id=1271
Comments Off on CAAR – US Agency for Healthcare Research and Quality Brief – December 29, 2020
October 29, 2020
“Medicare Part D: A First Look at Medicare Prescription Drug Plans in 2021,” by Juliette Cubanski and Anthony Damico (October 2020, HTML format).
www.kff.org/medicare/issue-brief/medicare-part-d-a-first-look-at-medicare-prescription-drug-plans-in-2021/
Comments Off on CAAR – Kaiser Family Foundation Issue Brief – October 29, 2020
August 20, 2020
“Mail Delays Could Affect Mail-Order Prescriptions for Millions of Medicare Part D and Large Employer Plan Enrollees,” by Juliette Cubanski, Jeannie Fuglesten Biniek, Matthew Rae, Anthony Damico, Brittni Frederiksen, and Alina Salganicoff (August 2020, HTML format).
www.kff.org/coronavirus-covid-19/issue-brief/mail-delays-could-affect-mail-order-prescriptions-for-millions-of-medicare-part-d-and-large-employer-plan-enrollees/
Comments Off on CAAR – Kaiser Family Foundation Issue Brief – August 20, 2020
July 9, 2020
“Loophole in Drug Payment Rule Continues To Cost Medicare and Beneficiaries Hundreds of Millions of Dollars,” (OEI-BL-20-00100, July 2020, .pdf format, 16p.).
oig.hhs.gov/oei/reports/OEI-BL-20-00100.asp
Comments Off on CAAR – US Department of Health and Human Service, Office of Inspector General Report – July 9, 2020
April 14, 2020
“Preventing Drug Diversion: Disposal of Controlled Substances in Home Hospice Settings,” (GAO-20-378, April 2020, .pdf format, 21p.).
www.gao.gov/products/GAO-20-378
Comments Off on CAAR – US Government Accountability Office Report – April 14, 2020
April 13, 2020
“The Elijah E. Cummings Lower Drug Costs Now Act: How It Would Work, How It Would Affect Prices, and What the Challenges Are,” by Paul B. Ginsburg and Steven M. Lieberman (April 2020, .pdf and HTML format, 8p.).
www.commonwealthfund.org/publications/issue-briefs/2020/apr/lower-drug-costs-now-act-hr3-how-it-would-work
Comments Off on CAAR – Commonwealth Fund Issue Brief – April 13, 2020
March 23, 2020
“Examining Current Medicare Part D Policies for Extended Supplies of Medication,” by Juliette Cubanski, Karyn Schwartz, and Anthony Damico (March 2020, HTML format).
www.kff.org/medicare/issue-brief/examining-current-medicare-part-d-policies-for-extended-supplies-of-medication/
Comments Off on CAAR – Kaiser Family Foundation Issue Brief – March 23, 2020
November 27, 2019
“A Look at Recent Proposals to Control Drug Spending by Medicare and its Beneficiaries,” by Meredith Freed, Juliette Cubanski, and Tricia Neuman (November 2019, .pdf and HTML format, 27p.).
www.kff.org/medicare/issue-brief/a-look-at-recent-proposals-to-control-drug-spending-by-medicare-and-its-beneficiaries/
Comments Off on CAAR – Kaiser Family Foundation Issue Brief – November 27, 2019
October 23, 2019
“Assessing Drug Price Increases in Medicare Part D and the Implications of Inflation Limits,” by Juliette Cubanski and Tricia Neuman (October 2019, .pdf format, 6p.).
www.kff.org/medicare/issue-brief/assessing-drug-price-increases-in-medicare-part-d-and-the-implications-of-inflation-limits/
Comments Off on CAAR – Kaiser Family Foundation Brief – October 23, 2019
October 1, 2019
“Key Provisions of Proposals on Drug Price Negotiation, Inflation Rebates, and Medicare Part D Redesign,” (September 2019, .pdf and HTML format, 2p.).
www.commonwealthfund.org/publications/2019/sep/key-provisions-proposals-drug-price-negotiation-inflation-rebates-part-d-redesign
Comments Off on CAAR – Commonwealth Fund Chart – October 1, 2019
September 27, 2019
“Making Prescription Drugs More Affordable: Legislation to Negotiate a Better Deal for Americans,” a hearing held September 25, 2019 (witness statements available in .pdf format, video available at the site, running time 4 hours 23 minutes). Note: Hearing starts at the 10:15 mark.
energycommerce.house.gov/committee-activity/hearings/hearing-on-making-prescription-drugs-more-affordable-legislation-to
Comments Off on CAAR – US House Committee on Energy and Commerce Hearing Testimony – September 27, 2019
“Medicare Part D’s Effect on Evergreening, Generics, and Drug Prices,” by Geoffrey T. Sanzenbacher and Gal Wettstein (IB No. 19-14, September 2019, .pdf and Excel format, 7p.).
crr.bc.edu/briefs/medicare-part-ds-effect-on-evergreening-generics-and-drug-prices/
Comments Off on CAAR – Center for Retirement Research at Boston College Issue Brief – September 27, 2019
September 26, 2019
“Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans, 2017 Year-End Update,” by Leigh Purvis and Dr. Stephen Schondelmeyer (September 2019, .pdf format, 17p.).
www.aarp.org/ppi/info-2019/trends-in-retail-prices-of-drugs.html
Comments Off on CAAR – AARP Public Policy Institute Report – September 26, 2019
Older Posts »